Principle of Assay
Human SLC25A13/Citrin ELISA Kit (A74552) is a 4 hour sandwich Enzyme-Linked Immunosorbent Assay (sELISA) designed for the in vitro quantitative determination of human SLC25A13/Citrin in serum, plasma, tissue homogenates, and other biological fluids. A 96-well microtiter plate has been pre-coated with an antibody specific for SLC25A13/Citrin. Standards and samples are added to the wells, where SLC25A13/Citrin binds to the immobilized capture antibody. Following incubation, unbound components are removed by washing and a biotinylated detection antibody specific for SLC25A13/Citrin is added to the wells. The detection antibody binds the captured SLC25A13/Citrin to form an antibody-antigen-antibody sandwich complex. After further incubation and washing, HRP-Streptavidin conjugate is added to the wells. TMB substrate solution is then added to visualize the HRP enzymatic reaction. This produces a blue-coloured product that changes to yellow following addition of acidic stop solution. The intensity of the yellow colour is directly proportional to the amount of SLC25A13/Citrin captured in each well. The concentration of SLC25A13/Citrin is calculated by reading the absorbance at 450 nm and comparing the values with the standard curve.